Article info
PDFShort report
Nasal fentanyl alone plus buccal midazolam: an open-label, randomised, controlled feasibility study in the dying
- Correspondence to Dr Paul Perkins, Sue Ryder Leckhampton Court Hospice, Cheltenham GL53 0QJ, UK; paul.perkins{at}suerydercare.org
Citation
Nasal fentanyl alone plus buccal midazolam: an open-label, randomised, controlled feasibility study in the dying
Publication history
- Received September 12, 2019
- Accepted April 9, 2020
- First published May 6, 2020.
Online issue publication
August 19, 2020
Article Versions
- Previous version (19 August 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.